(STI) Solidion Technology - Ratings and Ratios
Battery, Materials, Anode, Lithium-Ion, Solid-State
Description: STI Solidion Technology
Solidion Technology Inc. (NASDAQ:STI) is a US-based company specializing in the development and commercialization of advanced battery technologies, including materials, components, cells, and module/pack solutions. As a subsidiary of Global Graphene Group, Inc., Solidion leverages cutting-edge research and expertise to drive innovation in the field of lithium-ion batteries and beyond. With a focus on silicon-rich all-solid-state lithium-ion cells, anode-less lithium metal cells, and lithium-sulfur cells, the company is poised to capitalize on the growing demand for high-performance, safe, and sustainable energy storage solutions.
From a market perspective, Solidion Technology Inc. operates within the Electrical Components & Equipment sub-industry, a sector characterized by rapid technological advancements and increasing demand for clean energy solutions. As a publicly traded company listed on NASDAQ under the ticker symbol STI, Solidion is subject to the scrutiny of investors and analysts alike, with its financial performance and strategic decisions closely monitored.
Analyzing the provided
Based on the available data, a potential forecast for STI could be as follows: given the current oversold conditions and the companys strong RoE, we might see a potential reversal in the stock price in the near term. If the company can demonstrate progress in its technological developments and commercialization efforts, we could see a re-rating of the stock, potentially driving the price towards the SMA20 at $4.45. However, this would require a significant improvement in investor sentiment and a sustained upward trend. In the absence of such a catalyst, the stock may continue to trade within the current range, with potential support around the 52-week low of $3.02.
STI Stock Overview
Market Cap in USD | 19m |
Sub-Industry | Electrical Components & Equipment |
IPO / Inception | 2024-02-02 |
STI Stock Ratings
Growth Rating | -91.1% |
Fundamental | 55.0% |
Dividend Rating | - |
Return 12m vs S&P 500 | -75.4% |
Analyst Rating | - |
STI Dividends
Currently no dividends paidSTI Growth Ratios
Growth Correlation 3m | 0.4% |
Growth Correlation 12m | -79% |
Growth Correlation 5y | -87.4% |
CAGR 5y | -81.67% |
CAGR/Max DD 3y | -0.82 |
CAGR/Mean DD 3y | -0.98 |
Sharpe Ratio 12m | -1.20 |
Alpha | 0.19 |
Beta | 0.824 |
Volatility | 266.67% |
Current Volume | 71.9k |
Average Volume 20d | 71.9k |
Stop Loss | 4.2 (-8.7%) |
Signal | -0.34 |
Piotroski VR‑10 (Strict, 0-10) 2.5
Net Income (-8.84m TTM) > 0 and > 6% of Revenue (6% = 23.9k TTM) |
FCFTA -1.43 (>2.0%) and ΔFCFTA -75.77pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
NWC/Revenue -398.4% (prev -347.2k%; Δ 346.8kpp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
CFO/TA -1.33 (>3.0%) and CFO -7.09m > Net Income -8.84m (YES >=105%, WARN >=100%) |
Net Debt (1.76m) to EBITDA (3.19m) ratio: 0.55 <= 3.0 (WARN <= 3.5) |
Current Ratio 0.44 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
Outstanding Shares last Quarter (3.20m) change vs 12m ago 66.25% (target <= -2.0% for YES) |
Gross Margin 56.41% (prev -8449 %; Δ 8505 pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
Asset Turnover 6.67% (prev 0.10%; Δ 6.57pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
Interest Coverage Ratio 5.23 (EBITDA TTM 3.19m / Interest Expense TTM 562.9k) >= 6 (WARN >= 3) |
Altman Z'' -70.26
(A) -0.30 = (Total Current Assets 1.22m - Total Current Liabilities 2.81m) / Total Assets 5.33m |
(B) -19.97 = Retained Earnings (Balance) -106.5m / Total Assets 5.33m |
warn (B) unusual magnitude: -19.97 — check mapping/units |
(C) 0.49 = EBIT TTM 2.95m / Avg Total Assets 5.98m |
(D) -6.21 = Book Value of Equity -106.5m / Total Liabilities 17.2m |
Total Rating: -70.26 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 55.00
1. Piotroski 2.50pt = -2.50 |
2. FCF Yield -21.44% = -5.0 |
3. FCF Margin data missing |
4. Debt/Equity data missing |
5. Debt/Ebitda 5.09 = -2.50 |
6. ROIC - WACC (= 66.44)% = 12.50 |
7. RoE data missing |
8. Rev. Trend 40.90% = 3.07 |
9. EPS Trend -11.38% = -0.57 |
What is the price of STI shares?
Over the past week, the price has changed by -18.66%, over one month by +69.09%, over three months by +72.22% and over the past year by -70.48%.
Is Solidion Technology a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of STI is around 4.46 USD . This means that STI is currently overvalued and has a potential downside of -3.04%.
Is STI a buy, sell or hold?
What are the forecasts/targets for the STI price?
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 71.5 | 1454.3% |
Analysts Target Price | - | - |
ValueRay Target Price | 4.8 | 5% |
Last update: 2025-09-05 05:02
STI Fundamental Data Overview
CCE Cash And Equivalents = 114.7k USD (Cash And Short Term Investments, last quarter)
P/S = 4861.961
P/B = 663973.3535
Beta = 0.345
Revenue TTM = 398.6k USD
EBIT TTM = 2.95m USD
EBITDA TTM = 3.19m USD
Long Term Debt = 14.4m USD (from nonCurrentLiabilitiesTotal, last quarter)
Short Term Debt = 1.88m USD (from shortTermDebt, last quarter)
Debt = 16.2m USD (Calculated: Short Term 1.88m + Long Term 14.4m)
Net Debt = 1.76m USD (from netDebt column, last quarter)
Enterprise Value = 35.6m USD (19.4m + Debt 16.2m - CCE 114.7k)
Interest Coverage Ratio = 5.23 (Ebit TTM 2.95m / Interest Expense TTM 562.9k)
FCF Yield = -21.44% (FCF TTM -7.62m / Enterprise Value 35.6m)
FCF Margin = -1913 % (FCF TTM -7.62m / Revenue TTM 398.6k)
Net Margin = -2218 % (Net Income TTM -8.84m / Revenue TTM 398.6k)
Gross Margin = 56.41% ((Revenue TTM 398.6k - Cost of Revenue TTM 173.8k) / Revenue TTM)
Tobins Q-Ratio = -0.33 (set to none) (Enterprise Value 35.6m / Book Value Of Equity -106.5m)
Interest Expense / Debt = 0.69% (Interest Expense 112.5k / Debt 16.2m)
Taxrate = 0.0% (0.0 / 146.8k)
NOPAT = 2.95m (EBIT 2.95m * (1 - 0.00%))
Current Ratio = 0.44 (Total Current Assets 1.22m / Total Current Liabilities 2.81m)
Debt / EBITDA = 5.09 (Net Debt 1.76m / EBITDA 3.19m)
Debt / FCF = -2.13 (Debt 16.2m / FCF TTM -7.62m)
Total Stockholder Equity = -16.4m (last 4 quarters mean)
RoA = -165.7% (set to none)
RoE = unknown (Net Income TTM -8.84m / Total Stockholder Equity -16.4m)
RoCE = unknown (Ebit 2.95m / (Equity -16.4m + L.T.Debt 14.4m))
RoIC = 71.68% (Ebit 2.95m / (Assets 5.33m - Current Assets 1.22m))
WACC = 5.25% (E(19.4m)/V(35.7m) * Re(9.05%)) + (D(16.2m)/V(35.7m) * Rd(0.69%) * (1-Tc(0.0)))
Shares Correlation 3-Years: 84.46 | Cagr: 7.36%
Discount Rate = 9.05% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow -7.62m)
EPS Correlation: -11.38 | EPS CAGR: 79.54% | SUE: N/A | # QB: 0
Revenue Correlation: 40.90 | Revenue CAGR: 216.2% | SUE: N/A | # QB: None
Additional Sources for STI Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle